Previous studies (9) suggested that AKT pathways may be regulated by TRPC1 and our previous work revealed that TRPC1 plays an essential role in the inhibition of breast cancer progression by inhibiting the PI3K/AKT signaling pathway. This evidence concerns the gene AKT1 and breast carcinoma.